Recognizing the heterogeneity of DLBCL
Panel discussion on the treatment of adolescent and young adult lymphoma patients
Catherine Bollard et al.
Novel biological therapies for managing non-Hodgkin lymphoma
Upcoming trials for DLBCL: R-CHOP with acalabrutinib and obinutuzumab with checkpoint inhibitor
Updates from a Phase I clinical trial examining ublituximab in combination with TGR-1202